• Fund Type: SICAV
  • Objective: Foreign Blend
  • Asset Class: Equity
  • Geographic Focus: International

JPMorgan Funds - Global Unconstrained Equity Fund

+ Add to Watchlist

JPGEAAU:LX

14.82 USD 0.04 0.27%

As of 00:59:30 ET on 12/23/2014.

Snapshot for JPMorgan Funds - Global Unconstrained Equity Fund (JPGEAAU)

Year To Date: +5.41% 3-Month: 0.00% 3-Year: +14.69% 52-Week Range: 13.30 - 15.17
1-Month: -0.20% 1-Year: +7.39% 5-Year: +7.36% Beta vs MXWD000V: 1.03

Mutual Fund Chart for JPGEAAU

No chart data available.
  • JPGEAAU:LX 14.82
  • 1M
  • 1Y
Interactive JPGEAAU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for JPGEAAU

JPMorgan Funds - Global Unconstrained Equity Fund is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to provide long-term capital growth. The Fund invests primarily in equities, throughout the world. The Fund may invest, to a limited extent, in fixed-interest securities.

Inception Date: 03-31-2005 Telephone: 352-34-10-101 Tel
Managers: PETER KIRKMAN / TIM WOODHOUSE
Web Site: www.jpmorganassetmanagement.com

Fundamentals for JPGEAAU

NAV (on 2014-12-23) 14.82
Assets (M) (on 2014-12-23) 377.64
Fund Leveraged N
Minimum Investment 35,000.00
Minimum Subsequent Investment 5,000.00

Dividends for JPGEAAU

No dividends reported

Fees & Expenses for JPGEAAU

Front Load 5.00
Back Load 0.50
Current Mgmt Fee 1.50
Redemption Fee 0.50
12b1 Fee -
Expense Ratio 1.90

Top Fund Holdings for JPGEAAU

Filing Date: 08/31/2014
Name Position Value % of Total
JPMorgan Liquidity Funds - US 14,981,874 14,981,874 3.836%
Citigroup Inc 275,638 14,236,703 3.645%
Barclays PLC 3,049,728 11,418,672 2.924%
Johnson & Johnson 105,504 10,995,627 2.815%
Sanofi 96,283 10,589,801 2.711%
AXA SA 379,197 9,415,166 2.411%
Novartis AG 99,101 8,910,812 2.281%
QUALCOMM Inc 113,732 8,688,442 2.225%
Teradyne Inc 393,836 8,109,083 2.076%
Boston Scientific Corp 634,524 8,045,764 2.060%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil